Ϫ may be a useful tool by which to study the pathophysiology and pharmacology of NIS. thyroid; fluorescence microscopy; FRTL-5 cells
transport in the thyroid gland and other tissues and is of increasing importance as a therapeutic target and nuclear imaging reporter. NIS activity in vitro is currently measured with radiotracers and electrophysiological techniques. We report on the development of a novel live cell imaging assay of NIS activity using the I Ϫ -sensitive and genetically encodable yellow fluorescent protein (YFP) variant YFP-H148Q/I152L. In FRTL-5 thyrocytes stably expressing YFP-H148Q/I152L, I
Ϫ induced a rapid and reversible decrease in cellular fluorescence characterized by 1) high affinity for extracellular I Ϫ (35 M), 2) inhibition by the NIS inhibitor perchlorate, 3) extracellular Na ϩ dependence, and 4) TSH dependence, suggesting that fluorescence changes are due to I Ϫ influx via NIS. Individual cells within a population of FRTL-5 cells exhibited a 3.5-fold variation in the rate of NIS-mediated I Ϫ influx, illustrating the utility of YFP-H148Q/I152L to detect cell-to-cell difference in NIS activity. I Ϫ also caused a perchlorate-sensitive decrease in YFP-H148Q/I152L fluorescence in COS-7 cells expressing NIS but not in cells lacking NIS. These results demonstrate that YFP-H148Q/I152L is a sensitive biosensor of NIS-mediated I Ϫ uptake in thyroid cells and in nonthyroidal cells following gene transfer and suggest that fluorescence detection of cellular I
Ϫ may be a useful tool by which to study the pathophysiology and pharmacology of NIS. thyroid; fluorescence microscopy; FRTL-5 cells THE SODIUM IODIDE SYMPORTER (NIS) is responsible for the accumulation of iodide (I Ϫ ) in the thyroid gland, and its activity is essential for the synthesis of thyroid hormone (7) . It is located on the basolateral membrane of thyroid follicular cells, where it relies on the inward electrochemical gradient for Na ϩ to cotransport Na ϩ and I Ϫ into cells with a stoichiometry of 2:1. I Ϫ then diffuses across the apical membrane of thyrocytes into the follicular lumen, where iodination of thyroglobulin, the precursor of thyroid hormones, takes place. NIS expression is regulated by thyroid-stimulating hormone (TSH), which is released by the pituitary gland and interacts with TSH receptors present on the basolateral membrane of thyrocytes. NIS is selectively and competitively inhibited by perchlorate (ClO 4 Ϫ ), an agent used historically to treat thyrotoxicosis. Alterations in NIS expression and function are a feature of thyroid diseases. The intrinsic ability of the thyroid to accumulate I Ϫ has long been exploited clinically in the diagnosis and treatment of thyroid cancer with radioiodide. However, a significant proportion of patients with aggressive thyroid cancer fail to respond to radioiodide therapy, and no alternative treatment exists. The causes are unclear but may involve defects in NIS expression, maturation, and plasma membrane targeting (6, 19, 28) . Autoimmune thyroid disease is also associated with changes in NIS expression (3) and, in some cases, with the presence in serum of NIS autoantibodies (9) . Furthermore, NIS mutations in the "iodide transport defect" are a rare cause of congenital hypothyroidism (23) .
The role of NIS extends beyond the thyroid gland. NIS is normally expressed in extrathyroidal tissues including the lactating breast, salivary glands, gastric mucosa, placenta, and kidney (reviewed in Ref. 7) . The detection of NIS in breast and other extrathyroidal tumors, as well as the induction of NIS expression through gene transfer, raises the possibility of imaging and treating a wide range of cancers with radioiodide (27, 32) . In addition, NIS has been used as a noninvasive in vivo nuclear imaging reporter of gene expression, graft success, and stem cell migration (1, 2, 16) .
The role of NIS in thyroid physiology and pathophysiology and growing importance of NIS in cancer treatment and nuclear imaging highlights the need for cellular studies to define the mechanisms that regulate NIS expression and function, both in thyroidal and nonthyroidal cells. Critical to such studies is a cell-based assay by which to measure NIS activity. I Ϫ accumulation in thyrocytes is commonly measured with radiotracers ( 125 I Ϫ ) and electrophysiological techniques, and both approaches have been used to characterize the kinetics of I Ϫ transport by NIS (4, 10, 18, 33) . The advent of optical probes has facilitated the measurement of other ions. A quinoliniumbased fluorophore LZQ is sensitive to I Ϫ (but not Cl Ϫ ) and permits the measurement of I Ϫ /Cl Ϫ exchange in cell lines expressing the cystic fibrosis transmembrane conductance regulator (CFTR) (14) . The disadvantage of small-molecule probes is their requirement for cell loading and their poor retention within cells, problems that can been overcome by the use of genetically encodable fluorescent proteins that can be transcriptionally expressed in cells. Yellow fluorescent protein (YFP) is sensitive to halides (31) , and two variants with enhanced halide sensitivity, YFP-H148Q and YFP-H148Q/ I152L, have been used to measure cellular I Ϫ /Cl Ϫ exchange via CFTR (11, 12, 15) . The high affinity of YFP-H148Q/I152L for I Ϫ and 30-fold selectivity for I Ϫ over Cl Ϫ (K I of 1.9 mM and K Cl of 85 mM at pH 7.4) (11) makes it an interesting candidate as a potential sensor of NIS-mediated I Ϫ accumulation in the presence of physiological intracellular Cl Ϫ . The aim of the present study was to assess the utility of YFP-H148Q/I152L as a biosensor of cellular I Ϫ uptake via NIS. Rat thyroid FRTL-5 cells were chosen as the model in which to test this novel assay, since these cells express NIS endogenously and have been extensively used to characterize the kinetics of I Ϫ uptake with radiotracers and voltage clamp (18, 30, 33, 37) . In fact, the coding sequence of the NIS gene was first deduced from cDNA derived from FRTL-5 cells (4). Specific criteria were selected by which fluorescence changes induced by I Ϫ in these cells could be ascribed to NIS, including 1) sensitivity to micromolar extracellular I Ϫ , 2) inhibition by perchlorate, 3) extracellular Na ϩ dependence, and 4) regulation by TSH. The assay was further validated in COS-7 cells expressing human NIS (hNIS) to confirm the specificity of I Ϫ -induced fluorescence changes.
MATERIALS AND METHODS

Cell Culture
Fischer rat thyroid FRTL-5 cells (donated by F. Curcio and S. Ambesi-Impiombato, University of Udine, Italy) were cultured in Coon's modified F12 medium supplemented with 5% donor calf serum, 100 U/ml penicillin, 100 g/ml streptomycin, and a sixhormone mix (6H) containing 1 g/ml insulin, 3.6 ng/ml hydrocortisone, 5 g/ml apotransferrin, 10 ng/ml glycyl-L-histidyl-L-lysine acetate, 10 ng/ml somatostatin, and 1 mU/ml TSH. FRTL-5 cells were passaged with "CTC" solution consisting of 20 U/ml collagenase, 0.75 mg/ml trypsin, and 2% dialyzed chicken serum in Ca 2ϩ -and Mg 2ϩ -free Hanks' balanced salt solution. COS-7 cells (donated by S. Ferroni, University of Bologna) were cultured in DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin, and were passaged with 0.05% trypsin-EDTA solution.
Transfection
The pcDNA3.1 vector containing the YFP-H148Q/I152L coding sequence (pcDNA3.1-YFP-H148Q/I152L) was donated by A. Verkman (University of California), and the pcDNA3 vector containing the full-length hNIS coding sequence was donated by S. Jhiang (Ohio State University). The hNIS sequence was subcloned into a pcDNA3.1/Zeo vector at KpnI/XbaI sites and designated as pcDNA3.1/Zeo-hNIS. FRTL-5 cells grown in 24-well plates were transfected with 0.8 g/well of pcDNA3.1-YFP-H148Q/I152L using Lipofectamine 2000 (Invitrogen) at a ratio of 4 l liposome to 1 g DNA. Clonal populations of FRTL-5 cells stably expressing the fluorescent protein were generated by selection of antibiotic-resistant cells with 500 g/ml G418 for 2 wk and limited dilution of surviving cells. COS-7 cells were cotransfected with pcDNA3.1-YFP-H148Q/ I152L and either pcDNA3.1/Zeo-hNIS or the empty vector pcDNA3.1/Zeo. For transient transfection, COS-7 cells were grown in six-well plates containing round glass coverslips and double transfections carried out with 0.5 mg of each plasmid (1 mg/well total) and Fugene (Stratagene) at a ratio of 3 l Fugene to 1 g DNA. Fluorescence measurements were performed 48 -72 h after transient transfection.
Cellular YFP-H148Q/I152L Fluorescence Measurement
Fluorescence intensity was monitored continuously with a Zeiss Axiovert 200 inverted microscope equipped with an XBO xenon 75-W short arc lamp, Lambda 10C filter changer (Sutter Instrument), and XF104 -2 YFP filter set for excitation at 500 Ϯ 12.5 nm and emission at 545 Ϯ 17.5 nm (Omega Optical). Cellular YFP-H148Q/ I152L fluorescence was observed with a ϫ40 oil-immersion objective, and images were typically acquired for 100 ms every 10 s. Images were acquired with a Coolsnap HQ CCD camera (Roper Scientific) and processed with Metafluor software (Universal Imaging). Cells were grown on 25-mm diameter round glass coverslips and mounted in a thermostatically controlled imaging chamber (Warner Instruments) maintained at 36.5-37°C. Cells were continuously perfused at 4-5 ml min Ϫ1 with phosphate-buffered saline (PBS) composed of 137 mM NaCl, 2.7 mM KCl, 0.7 mM CaCl2, 1.1 mM MgCl2, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, and 10 mM glucose (pH 7.4). Cells were exposed to I Ϫ concentrations ranging from 1 M to 100 mM by replacing specified amounts of NaCl with equimolar NaI and maintaining the total concentration of NaCl plus NaI at 137 mM. To examine the effect of extracellular Na ϩ on fluorescence changes induced by I Ϫ , experiments were performed in a HEPES-buffered solution (HBS) composed of 145 mM NaCl, 5 mM KCl, 0.7 mM CaCl 2, 1.1 mM MgCl2, 10 mM HEPES, and 10 mM glucose (pH 7.4). Low-Na ϩ HBS containing 10 mM Na ϩ was prepared by replacing NaCl with equimolar choline chloride. The effect of pH on cellular YFP-H148Q/I152L fluorescence in FRTL-5 cells was determined by exposing cells to a high-K ϩ solution (10 mM HEPES, 130 mM KCl, 0.7 mM CaCl 2) at pH 6.5-7.5 in the presence of 7 M nigericin and 5 M valinomycin.
Analysis of Cellular YFP-H148Q/I152L Fluorescence
Typically, measurements of fluorescence intensity were performed on groups of 20 -100 FRTL-5 cells and 5-15 COS-7 cells, and represent the average intensity of all fluorescent cells within the selected region of interest. Cell-to-cell variability was determined by selecting 50 individual cells within a representative group of cells. Background fluorescence, measured in an area of the coverslip without cells, was subtracted from cellular fluorescence and was typically Ͻ10% of total fluorescence (mean background fluorescence 8.7 Ϯ 0.5%, n ϭ 45). Autofluorescence of cells not transfected with YFP-H148Q/I152L was negligible compared with the fluorescence of the coverslip itself. Photobleaching resulted in a one-phase exponential decrease in cellular YFP-H148Q/I152L fluorescence, occurring with a mean rate constant of 0.0033 Ϯ 0.0003 min Ϫ1 (n ϭ 45) with exposure times of 100 ms every 10 s. To correct for photobleaching, fluorescence intensity in the absence of iodide (F 0) was fitted to a one-phase exponential decay function to obtain a theoretical curve of F 0 at each time point. Fluorescence intensity during I Ϫ exposure (F) was then normalized to F0 to obtain a measure of relative fluorescence (RF) at each time point (i.e., RF ϭ F/F0). Changes in fluorescence induced by I Ϫ are expressed in terms of the maximal rate of fluorescence decrease (⌬RF/⌬t) and the steady-state decrease measured at 5 min of I Ϫ exposure (⌬RF5min). Both are negative values, reflecting a decrease in fluorescence, but are reported by their absolute values throughout. ⌬RF/⌬t was estimated as the initial or maximal slope of the best-fit curve when the I Ϫ induced decrease in RF was fitted by nonlinear regression to one-phase or, more commonly, a two-phase exponential decay function.
The concentration dependence of I Ϫ -induced changes in fluorescence was analyzed by nonlinear regression fitting to a biphasic Hill equation
where Y is the response in terms of ⌬RF/⌬t; Ymin and Ymax are the minimal and maximal responses, respectively; KH and KL are the affinity constants (defined as the extracellular I Ϫ concentrations producing a half-maximal response) for the high-and low-affinity components of the response; nH and nL are the Hill coefficients for highand low-affinity components; and ␣ H is the fraction of the response mediated by the high-affinity component. Curve fitting and other data analysis was performed with Prism 4 (GraphPad Software).
I Ϫ Sensitivity and pH Sensitivity of YFP-H148Q/I152L in Solution
The I Ϫ sensitivity and pH sensitivity of thyrocyte-derived YFP-H148Q/I152L was determined in solution. YFP-H148Q/I152L-expressing FRTL-5 cells were cultured in 150-cm 2 flasks (10 -20 ϫ 10 6 cells/flask), trypsinized, and centrifuged at 1,500 rpm. Pelleted cells were lysed by resuspension in 100 l of 10 mM HEPES and two freeze-thaw cycles. The lysate was centrifuged at 12,000 rpm, and the supernatant was collected. Droplets of a volume of 12 l of the YFP-H148Q/I152L-containing supernatant were deposited on a coverslip, and fluorescence images acquired with a ϫ10 objective (to allow Ͼ90% of the droplet to be imaged). The pH sensitivity of YFP-H148Q/I152L fluorescence was determined by adjusting the pH of the supernatant to various pH values with NaOH (final Na ϩ Ͻ 3 mM). Fluorescence intensity at each pH value was normalized to that at pH 7, and the pK a (pH at half-maximal fluorescence) was derived by nonlinear regression fitting to a sigmoidal curve. I Ϫ sensitivity was determined by adding 0 -100 mM NaI or reciprocal amounts of sodium gluconate to the supernatant, maintaining the total concentration of NaI plus sodium gluconate at 100 mM. Fluorescence intensity in the presence of I Ϫ was normalized to fluorescence in the absence of I Ϫ and fitted to the one-site binding equation
, where Y is the relative fluorescence in the presence of I Ϫ , a is the maximal decrease in relative fluorescence produced by a high I Ϫ concentration, and KI is the I Ϫ concentration producing a halfmaximal fluorescence decrease.
Intracellular pH Measurement
Intracellular pH (pHi) was measured with BCECF in FRTL-5 cells not expressing YFP-H148Q/I152L. Cells were loaded with 10 M BCECF-AM for 30 -60 min in culture medium, maintained for a further 20 min in culture medium to allow hydrolysis of BCECF-AM, and mounted as above in the imaging chamber. Fluorescence was monitored by fluorescence microscopy with the same filter set as YFP-H148Q/I152L (excitation 500 Ϯ 12.5 nm, emission 545 Ϯ 17.5 nm). Because of the higher intensity and photobleaching-induced decay of BCECF fluorescence, cells were visualized with a ϫ20 objective, rather than the ϫ40 objective used for YFP-H148Q/I152L experiments. Images were acquired for 200 ms every 10 s. The effect of I Ϫ on BCECF fluorescence was determined by replacing 1 mM NaCl in PBS with 1 mM NaI. The effect of pH was determined by exposing cells to a high-K ϩ solution (10 mM HEPES, 130 mM KCl, 0.7 mM CaCl 2) at pH 6.5-7.5 in the presence of 7 M nigericin and 5 M valinomycin. Fluorescence changes were expressed relative to resting fluorescence, which in the absence of specific manipulations, was stable for at least 30 min. Cell-to-cell variability in I Ϫ -induced responses was assessed by measuring fluorescence changes induced by 100 M I Ϫ in 50 individual cells chosen at random within a clonal population of FRTL-5 cells (Fig. 2, A-D) . Individual cells varied both in terms of the maximal rate of fluorescence decrease induced by I Ϫ (⌬RF/⌬t) and the steady-state decrease measured at 5 min of I Ϫ exposure (⌬RF 5min ). Neither parameter correlated with the resting fluorescence of cells (Fig. 2E) , suggesting that cell-to-cell variability in I Ϫ -induced responses is independent of differences in YFP-H148Q/I152L expression between cells. In contrast, there was a significant correlation between ⌬RF/⌬t and ⌬RF 5min (P Ͻ 0.001, R 2 ϭ 0.59) (Fig. 2F ), suggesting that cell-to-cell differences in the rate of I Ϫ influx result in parallel differences in intracellular I Ϫ concentration. (Fig. 3A) . The maximal rate of fluorescence decrease exhibited a biphasic I Ϫ concentration dependence, with high-and low-affinity constants of 35 M and Ͼ1 mM, respectively (Fig. 3B) .
RESULTS
Effect of I
Sensitivity to the NIS inhibitor perchlorate. I Ϫ -induced changes in YFP-H148Q/I152L fluorescence in FRTL-5 cells were inhibited by perchlorate (Fig. 4) . Regulation by TSH. FRTL-5 cells are routinely cultured in medium containing 1 mU/ml TSH. To examine the effect of TSH withdrawal, cells were seeded in medium containing TSH, allowed 2-4 days to adhere and begin replicating, and cultured for a further 7 days in medium containing or lacking TSH. Growth in TSH-deprived medium caused a 97% and 90% inhibition of the maximal rate of fluorescence decrease induced by 100 M and 10 mM I Ϫ , respectively (Fig. 6) .
Effect of I Ϫ on YFP-H148Q/I152L Fluorescence in hNISExpressing COS-7 Cells
I Ϫ -induced changes in fluorescence of COS-7 cells were examined 48 -72 h following cotransfection with YFP-H148Q/ I152L cDNA and either hNIS cDNA or empty vector. I Ϫ (100 M) decreased YFP-H148Q/I152L fluorescence in cells transfected with hNIS cDNA but had no effect on cells lacking hNIS (Fig. 7, A and B) . This response was prevented by pretreatment of cells with 100 M perchlorate, confirming that it is specifically mediated by NIS (Fig. 7C) . I Ϫ (10 mM) also (1 mM) had no effect on BCECF fluorescence (Fig. 8A) . In contrast, altering pH i to values of 7.5 and 6.5 with a high-K ϩ / nigericin/valinomycin buffer, respectively, increased and decreased BCECF fluorescence, confirming its pH sensitivity. Second, the effect of pH i alterations on YFP-H148Q/I152L fluorescence in FRTL-5 cells was examined by exposing cells to the same high-K ϩ /nigericin/valinomycin buffer, and this resulted in qualitatively similar changes in fluorescence as with BCECF. Thus, raising pH i to 7.5 increased YFP-H148Q/I152L fluorescence, and decreasing pH i to 6.5 reduced fluorescence (Fig. 8B) . Next, the pH sensitivity of thyrocyte-derived YFP-H148Q/I152L fluorescence was measured in solution and yielded a pK a of 7.02 (Fig. 8C ). Considering a typical pH i of 7.0, a physiological pH change of Ϯ0.2 units would result in a Ϯ15% change in resting YFP-H148Q/I152L fluorescence. Finally, the effect of pH on the I Ϫ sensitivity of thyrocytederived YFP-H148Q/I152L fluorescence was measured in solution over a physiological pH range of 6.8 -7.2. The affinity of YFP-H148Q/I152L for I Ϫ (K I ) was 1.4, 2.0, and 2.4 mM at pH values of 6.8, 7, and 7.2, respectively (Fig. 8D) , suggesting a small decrease in I Ϫ sensitivity with increasing pH. Considering a typical pH i of 7.0, a physiological pH change of Ϯ0.2 units would cause, at most, a 15% change in the magnitude of the fluorescence decrease induced by millimolar intracellular I Ϫ , with acidification increasing the response to I Ϫ , and alkalinization decreasing it.
DISCUSSION
The results of this study demonstrate the utility of YFP-H148Q/I152L as a cellular biosensor of NIS-mediated I accumulation both in thyroid cells and in nonthyroidal cells following NIS gene transfer. The fluorescence assay is sensitive and allows rapid changes in intracellular I Ϫ to be continuously monitored. I Ϫ -induced fluorescence changes are reversible and reproducible, permitting the acute effects of drugs and other manipulations on transport kinetics to be easily assessed. Furthermore, the assay can be performed on a small number of cells and can reveal differences in NIS activity in individual cells within a population. (4, 10, 18, 33) . In this study, I
Validation of New Method
Ϫ exposure was carried out isotonically by replacing specified amounts of NaCl with equimolar NaI while maintaining the total concentration of NaCl plus NaI constant. For solutions containing less than 1 mM I Ϫ , substitution of NaCl with NaI produces a negligible change in Cl Ϫ concentration, and fluorescence changes can be considered to be solely due to I Ϫ accumulation. However, solutions containing more than 1 mM I Ϫ have a reduced Cl Ϫ concentration, and fluorescence changes reflect the combined effects of I Ϫ influx and Cl Ϫ efflux (I Ϫ /Cl Ϫ from the thyroid in vivo, and this represents the basis for the perchlorate discharge test used to detect I Ϫ organification defects in patients (13) .
TSH is the main regulator of thyroid function and is necessary to maintain the I Ϫ -concentrating capability of FRTL-5 Ϫ in HEPES-buffered solution containing normal Na ϩ (145 mM), a second response to I Ϫ after reducing Na ϩ to 10 mM by equimolar replacement with choline, and a third response to I Ϫ in the presence of normal Na ϩ . C: effect of low Na ϩ on the maximal rate of fluorescence change (⌬RF/⌬t) induced by I Ϫ . Bars represent mean Ϯ SE of n ϭ 5-6 separate experiments.
cells. TSH regulates I
Ϫ uptake through transcriptional and posttranscriptional mechanisms, including regulation of NIS mRNA expression and protein synthesis and subsequent targeting to and retention at the plasma membrane (17, 24) . TSH withdrawal for 1 wk results in the loss of 125 I Ϫ accumulation in FRTL-5 cells (33) and, in this study, the loss of the fluorescence response to 100 M I Ϫ , a concentration that is selective for NIS-mediated transport.
The specificity of NIS-dependent changes in cellular YFP-H148Q/I152L fluorescence was further confirmed in COS-7 cells expressing recombinant hNIS. Cells cotransfected transiently with hNIS and YFP-H148Q/I152L cDNAs exhibited a perchlorate-sensitive decrease in fluorescence in response to 100 M I Ϫ , whereas cells expressing only the fluorochrome did not. These results are in agreement with the demonstration of perchlorate-inhibitable 125 I uptake in COS-7 cells expressing hNIS (26) . Fluorescence responses in NIS-expressing COS-7 cells were smaller than in FRTL-5 cells, suggesting lower NIS activity.
A potential concern with the use of YFP-H148Q/I152L as an I Ϫ biosensor is its pH sensitivity, with acidification causing a reduction in fluorescence emission and an increase in I Ϫ sensitivity. Thyrocyte-derived YFP-H148Q/I152L in solution exhibited an apparent pK a of 7.02, similar to the pK a of 6.92 of purified bacterial protein (11) . The I Ϫ sensitivity of thyrocytederived YFP-H148Q/I152L was also pH dependent, with a shift in affinity from 1.4 mM at pH 6.8 to 2.4 mM at pH 7.2. Suppression of YFP fluorescence by halides is due to protonation of the chromophore (31) and involves ground-state binding to a unique site close to the chromophore, where it alters the electrostatic environment producing a change in apparent pK a (15) . It is therefore possible that drug treatments and other manipulations may alter the response of YFP-H148Q/I152L to I Ϫ by changing pH i and hence the apparent affinity for the halide. We estimated that a pH change of 0.2 units causes, at most, a 15% change in YFP-H148Q/I152L fluorescence intensity and in I Ϫ -induced fluorescence responses, suggesting that physiological variations in pH i have a small impact upon fluorescence responses of intact cells. Nevertheless, independent measurements of pH i are necessary to rule out pH as a factor in modulating the response of YFP-H148Q/I152L to I Ϫ when cells are exposed to drugs or other treatments. I
Ϫ itself had no effect on pH i in FRTL-5 cells measured with BCECF, confirming that suppression of cellular YFP-H148Q/I152L fluorescence by extracellular I Ϫ is not due to intracellular acidification.
Advantages and Applications of New Method
Live cell imaging with YFP-H148Q/I152L enables rapid changes in intracellular I Ϫ concentration to be monitored. In FRTL-5 cells, exposure to extracellular I Ϫ causes a decrease in YFP-H148Q/I152L fluorescence within 10 s. Radiotracer uptake studies typically measure I Ϫ uptake over time periods ranging from a few minutes to over an hour (4, 18, 30, 33) and are inaccurate at shorter time intervals because of the need to remove extracellular radioactivity. The fluorescence assay is therefore particularly useful in detecting early time points of I Ϫ uptake that are difficult to measure with radiotracers.
Assays based upon cell imaging techniques allow measurements on single cells and permit functional differences between cells in a population to be assessed. In a clonal population of FRTL-5 cells, there was a 3.5-fold variation in the rate of I Ϫ uptake via NIS (measured as ⌬RF/⌬t) and a 2. tissue exhibiting NIS immunoreactivity (3). The major obstacle to the application of the fluorescence assay to cells in primary culture is the difficulty of transfecting these cells. This may be overcome with virus-mediated gene delivery, with a 95% transduction efficiency reported for adenoviral transfer of the LacZ gene into normal human thyroid cells (21) . Adenoviral delivery also permits thyroid-targeted gene expression in primary human thyrocytes using the thyroglobulin promoter and a Cre/loxP system. (20) . Given that cell imaging allows I Ϫ concentration to be monitored only in YFP-H148Q/I152L-expressing cells, a high transduction efficiency is needed to ensure that fluorescent cells are representative of the entire population. Transient virus-mediated expression of YFP-H148Q/I152L in primary cultures derived from thyroid carcinomas may also benefit the characterization of the changes in NIS activity occurring in thyroid cancer.
NIS gene transfer is being increasingly considered as a means of rendering tumors sensitive to radioiodide therapy (27) and as a nuclear imaging reporter of gene expression, graft success, and stem cell migration (1, 2, 16) . Cell imaging with YFP-H148Q/I152L may be a useful in vitro assay by which to assess the success of NIS gene transfer by providing an estimate of the proportion of cells with NIS activity. This is not possible with radiotracers, which measure mean I Ϫ uptake in a sample containing thousands of cells. Furthermore, the fluorescence assay may be useful in testing the ability of tissuespecific promoters to selectively induce NIS expression in specific cell types. Targeted NIS expression is necessary for cancer gene therapy to limit radioiodide ablation to malignant cells.
YFP-H148Q/I152L may be useful not only to study NISmediated I Ϫ uptake but also to characterize pathways of I Ϫ efflux. Steady-state fluorescence in the presence of extracellular I Ϫ reflects the balance of I Ϫ influx and efflux, and preventing further influx with perchlorate or by removing extracellular I Ϫ results in the complete recovery of resting fluorescence due to I Ϫ efflux. Several pathways may mediate I Ϫ efflux including pendrin (25) , a TSH-stimulated Ca 2ϩ -dependent pathway (34) , and a TSH/cAMP-activated Cl enhance I Ϫ accumulation in the thyroid, by increasing the expression, plasma membrane targeting, and activity of NIS, may be useful in restoring the effectiveness of radioiodide therapy in patients with unresponsive thyroid cancer. NIS in extrathyroidal tumors is predominantly intracellular (32) , and agents that promote surface localization may be useful in rendering these tumors sensitive to radioiodide imaging and ablation. Furthermore, compounds that inhibit I Ϫ efflux may be useful in promoting radioiodide retention by metastatic thyroid tumor cells and by nonthyroidal cells expressing NIS endogenously or following gene transfer. In these cells, the absence of a follicular structure and I Ϫ organification results in rapid loss of cellular radioactivity, which limits the effectiveness of radioiodide therapy. Identification of compounds that alter I Ϫ -induced fluorescence responses in a cell-based YFP-H148Q/I152L assay must be followed by secondary assays to eliminate false positives. Other assays include measurement of pH i to rule out pH-mediated changes in the I Ϫ sensitivity of YFP-H148Q/I152L fluorescence and measurement of YFP-H148Q/I152L fluorescence in solution to rule out a direct interaction of compounds with YFP-H148Q/I152L. Given these precautions, high-throughput screening with YFP-H148Q/I152L may be useful in identifying therapeutic compounds that increase cellular uptake and retention of radioiodide for the diagnosis and treatment of thyroidal and extrathyroidal cancer.
In conclusion, YFP-H148Q/I152L is a promising biosensor of I Ϫ accumulation in cells expressing NIS endogenously or following gene transfer and represents a new tool with which to study NIS function and identify novel therapeutic compounds for the treatment of defective I Ϫ transport.
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